Understanding variability in posaconazole exposure using an integrated population pharmacokinetic analysis.
Dolton, Michael J
Understanding variability in posaconazole exposure using an integrated population pharmacokinetic analysis. [electronic resource] - Antimicrobial agents and chemotherapy Nov 2014 - 6879-85 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1098-6596
10.1128/AAC.03777-14 doi
Adult
Anti-HIV Agents--pharmacology
Anticonvulsants--pharmacology
Antiemetics--pharmacology
Antifungal Agents--pharmacokinetics
Biological Availability
Carbamates--pharmacology
Drug Interactions
Drug Therapy, Combination--adverse effects
Furans
Healthy Volunteers
Humans
Metoclopramide--pharmacology
Nucleic Acid Synthesis Inhibitors--pharmacology
Organophosphates--pharmacology
Phenytoin--pharmacology
Proton Pump Inhibitors--pharmacology
Rifampin--pharmacology
Sulfonamides--pharmacology
Triazoles--adverse effects
Understanding variability in posaconazole exposure using an integrated population pharmacokinetic analysis. [electronic resource] - Antimicrobial agents and chemotherapy Nov 2014 - 6879-85 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1098-6596
10.1128/AAC.03777-14 doi
Adult
Anti-HIV Agents--pharmacology
Anticonvulsants--pharmacology
Antiemetics--pharmacology
Antifungal Agents--pharmacokinetics
Biological Availability
Carbamates--pharmacology
Drug Interactions
Drug Therapy, Combination--adverse effects
Furans
Healthy Volunteers
Humans
Metoclopramide--pharmacology
Nucleic Acid Synthesis Inhibitors--pharmacology
Organophosphates--pharmacology
Phenytoin--pharmacology
Proton Pump Inhibitors--pharmacology
Rifampin--pharmacology
Sulfonamides--pharmacology
Triazoles--adverse effects